Evaluation of Optical Coherence Tomography for the Measurement of the Effects of Activators and Anticoagulants on the Blood Coagulation In Vitro

Optical properties of human blood during coagulation was studied using optical coherence tomography (OCT) and the parameter of clotting time derived from the 1/e light penetration depth (d_1/e) vs. time was developed in our previous work. In this study, in order to know if a new optical coherence tomography test can characterize the blood coagulation process under different treatments in vitro, the effects of two different activators (calcium ions and thrombin) and anticoagulants, i.e., acetylsalicylic acid (ASA, a well-known drug aspirin) and melagatran (a direct thrombin inhibitor), at various concentrations are evaluated. A swept source OCT system with a 1300 nm center wavelength is used for detecting the blood coagulation process in vitro under a static condition. A dynamic study of the d_1/e reveals a typical behavior due to coagulation induced by both calcium ions and thrombin, and the clotting time is concentration-dependent. Dose-dependent ASA and melagatran prolong the clotting times. ASA and melagatran have different effects on blood coagulation. As expected, melagatran is much more effective than ASA in anticoagulation by the OCT measurements. The OCT assay appears to be a simple method for the measurement of blood coagulation to assess the effects of activators and anticoagulants, which can be used for activator and anticoagulant screening.